Augmedix (AUGX) vs. Its Rivals Financial Review

Augmedix (OTCMKTS:AUGXGet Rating) is one of 226 public companies in the “Business services, not elsewhere classified” industry, but how does it weigh in compared to its peers? We will compare Augmedix to similar companies based on the strength of its earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Valuation & Earnings

This table compares Augmedix and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Augmedix $22.17 million -$17.85 million -3.98
Augmedix Competitors $3.24 billion $428.85 million 15.69

Augmedix’s peers have higher revenue and earnings than Augmedix. Augmedix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Augmedix and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Augmedix 0 0 5 0 3.00
Augmedix Competitors 1397 6873 12223 347 2.55

Augmedix currently has a consensus target price of $6.75, suggesting a potential upside of 182.43%. As a group, “Business services, not elsewhere classified” companies have a potential upside of 55.97%. Given Augmedix’s stronger consensus rating and higher probable upside, analysts clearly believe Augmedix is more favorable than its peers.

Profitability

This table compares Augmedix and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Augmedix -77.52% -251.74% -53.94%
Augmedix Competitors -15.48% -15.22% -6.55%

Insider and Institutional Ownership

59.0% of Augmedix shares are held by institutional investors. Comparatively, 59.8% of shares of all “Business services, not elsewhere classified” companies are held by institutional investors. 13.9% of shares of all “Business services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Augmedix peers beat Augmedix on 9 of the 12 factors compared.

Augmedix Company Profile (Get Rating)

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive News & Ratings for Augmedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Augmedix and related companies with MarketBeat.com's FREE daily email newsletter.